11/26
12:30 am
oprx
How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]
Low
Report
How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]
11/18
01:18 pm
oprx
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
07:21 am
oprx
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/17
08:06 am
oprx
OptimizeRx (NASDAQ:OPRX) had its price target lowered by analysts at Stephens from $20.00 to $17.00. They now have an "equal weight" rating on the stock.
Medium
Report
OptimizeRx (NASDAQ:OPRX) had its price target lowered by analysts at Stephens from $20.00 to $17.00. They now have an "equal weight" rating on the stock.
11/10
12:38 am
oprx
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/8
07:05 pm
oprx
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts [Yahoo! Finance]
Medium
Report
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts [Yahoo! Finance]
11/8
01:17 pm
oprx
Medium
Report
11/7
09:06 am
oprx
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at Citizens Jmp from $23.00 to $24.00. They now have a "market outperform" rating on the stock.
High
Report
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at Citizens Jmp from $23.00 to $24.00. They now have a "market outperform" rating on the stock.
11/7
05:59 am
oprx
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
04:01 pm
oprx
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
High
Report
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
10/20
08:00 am
oprx
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
Low
Report
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
10/10
08:53 am
oprx
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at JMP Securities from $20.00 to $23.00. They now have a "market outperform" rating on the stock.
Low
Report
OptimizeRx (NASDAQ:OPRX) had its price target raised by analysts at JMP Securities from $20.00 to $23.00. They now have a "market outperform" rating on the stock.
10/10
07:20 am
oprx
OptimizeRx (NASDAQ:OPRX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
OptimizeRx (NASDAQ:OPRX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
10/10
07:19 am
oprx
OptimizeRx (NASDAQ:OPRX) was given a new $23.00 price target on by analysts at UBS Group AG.
Low
Report
OptimizeRx (NASDAQ:OPRX) was given a new $23.00 price target on by analysts at UBS Group AG.
10/9
07:15 am
oprx
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/7
10:06 pm
oprx
OptimizeRx: How The Stock Is Changing Pharma Marketing [Seeking Alpha]
Medium
Report
OptimizeRx: How The Stock Is Changing Pharma Marketing [Seeking Alpha]
9/30
12:38 pm
oprx
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? [Yahoo! Finance]
Low
Report
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? [Yahoo! Finance]
9/23
08:14 am
oprx
Institutional investors have a lot riding on OptimizeRx Corporation (NASDAQ:OPRX) with 65% ownership [Yahoo! Finance]
Low
Report
Institutional investors have a lot riding on OptimizeRx Corporation (NASDAQ:OPRX) with 65% ownership [Yahoo! Finance]
9/10
07:51 am
oprx
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference [Yahoo! Finance]
Low
Report
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference [Yahoo! Finance]
9/10
07:30 am
oprx
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
Low
Report
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
9/9
04:22 pm
oprx
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising [Yahoo! Finance]
Low
Report
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising [Yahoo! Finance]
9/9
04:05 pm
oprx
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Low
Report
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
9/9
05:56 am
oprx
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.